Global biopharmaceutical company Takeda has launched an innovation capability centre (ICC) in Bengaluru, India, joining existing facilities in Slovakia and Mexico. The Bengaluru ICC will focus on ...

Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus on Tuesday to celebrate a milestone for the Japanese drugmaker’s new R&D tower. More than 250 ...

Takeda-backed Ascentage Pharma Group (AAPG) has filed to raise up to $100M through a U.S. initial public offering. The Chinese drug developer didn't specify terms in its SEC filing, but indicated ...

Takeda has bolstered its neuroscience pipeline by licensing drug candidates from California biotech AcuraStem targeting PIKfyve, which is gathering attention as a drug target in amyotrophic ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

Ramelteon acts as an MT 1 and MT 2 melatonin receptor agonist, showing higher affinities for these receptors than does the natural ligand Ramelteon induces sleep initiation and maintenance, as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: January 24 at 5:05:00 PM EST Loading Chart for TAK ...

1 Day TAK 0.54% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.52% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...